Combined effect of topotecan and irradiation on the survival and the induction of chromosome aberrations in vitro

Strahlentherapie und Onkologie

Volumn 178, Issue 9, 2002, Pages 497-503

  Rave Fränk, Margret ^a   Glomme, Sabine ^a   Hertig, Jens ^a   Weiss, Elisabeth ^a   Pradier, Olivier ^a   Hess, Clemens F ^a   Virsik Köpp, Patricia ^a   Schmidberger, Heinz ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Chromosome aberrations; Radiosensitivity; Topotecan

Indexed keywords

TOPOTECAN;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL SURVIVAL; CHROMOSOME ABERRATION; CLONOGENIC ASSAY; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; DNA TRANSCRIPTION; GENE MUTATION; HUMAN; HUMAN CELL; METAPHASE; RADIATION DOSE FRACTIONATION; RADIOSENSITIZATION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL LINE; CELL SURVIVAL; CHROMOSOME ABERRATIONS; COLONIC NEOPLASMS; FIBROBLASTS; GLIOBLASTOMA; HUMANS; LYMPHOCYTES; METAPHASE; NEOPLASMS; RADIATION DOSAGE; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; TIME FACTORS; TOPOTECAN; TUMOR CELLS, CULTURED;

EID: 0036729248     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-002-0959-y     Document Type: Article

References (25)

1. Differentiation of fibroblast stem cells
2. Posttreatment exposure to camptothecin enhances the lethal effects of X-rays on radioresistant human malignant melanoma cells
3. Apoptosis as a determinant of tumour sensitivity to topotecan in human ovarian tumours: Preclinical in vitro/in vivo studies
4. Characterization of camptothecin-resistant Chinese hamster lung cells
5. DNA topoisomerase I-targeting drugs as radiation sensitizers
6. Acquired camptothecin resitance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repair
7. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells
8. Acute toxicity and changes in quality of life during a combined radio-chemotherapy of glioblastomas with topotecan (Hycamtin)
9. CPT-11 in human colon-cancer cell lines and xenografts: Characterization of cellular sensitivity determinants
10. Cytotoxic activity of topotecan in human tumour cell Lines and primary cultures of human tumour cells from patients
11. Dependence of the frequency of harlequin-stained cells on BrdU concentration in human lymphocyte cultures
12. Concentration and timing dependence of Lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation
13. Mechanism of action of camptothecin
14. Interaction of ionizing radiation with topotecan in two human tumor cell Lines
15. Donor-age-related changes in the morphology, growth potential and collagen biosynthesis in rat fibroblast subpopulations in vitro
16. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: Evidence for cell cycle-independent toxicity
17. Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI Anticancer Drug Screen: Multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways
18. Differential response of tumor cells and normal fibroblasts normal to fractionated combined treatment with topotecan and ionizing radiation
19. The underlying cellular mechanism of fibrosis
20. Topoisomerase-I-inhibitor mit potentiell strahlensensibilisierender wirkung
21. Glioma cell sensitivity to topotecan: The role of p53 and topotecan-induced DNA damage
22. Influence of apoptosis on the enhancement of radiotoxicity by ouabain
23. Chromosomal aberrations induced in mice bone marrow by treating with cisplatin and irradiation
24. Topoisomerase I activity and cellular response to radiation in Chinese hamster cells
25. A model for tumor cell killing by topoisomerase poisons